From: Prognostic value of noggin protein expression in patients with resected gastric cancer
 | Noggin (invasive) | RBPMS2 (invasive) | Noggin (center) | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Low | High | Total | Low | High | Total | Low | High | Total | ||
RBPMS2 (invasive) | Low | 62 (84.9%) | 32 (35.6%) | 94 (57.7%) | Â | Â | Â | Â | Â | Â |
High | 11 (15.1%) | 58 (64.4%) | 69 (42.3%) | Â | Â | Â | Â | Â | Â | |
Total | 73,(100.0%) | 90(100.0%) | 163,(100.0%) | Â | Â | Â | Â | Â | Â | |
p-value |              <  0.001 |  |  | |||||||
Noggin (center) | Low | 54 (74.0%) | 18 (20.0%) | 72 (44.2%) | 53 (56.4%) | 19 (27.5%) | 72 (44.2%) | Â | Â | Â |
High | 19 (26.0%) | 72 (80.0%) | 91 (55.8%) | 41 (43.6%) | 50 (72.5%) | 91 (55.8%) | Â | Â | Â | |
Total | 73(100.0%) | 90(100.0%) | 163(100.0%) | 94(100.0%) | 69(100.0%) | 163(100.0%) | Â | Â | Â | |
p-value |              <  0.001 |             < 0.001 |  | |||||||
RBPMS2 (center) | Low | 51 (69.9%) | 26 (28.9%) | 77 (47.2%) | 70 (74.5%) | 7 (10.1%) | 78 (47.2%) | 48 (66.7%) | 29 (31.9%) | 77 (47.2%) |
High | 22 (30.1%) | 64 (71.1%) | 86 (52.8%) | 24 (25.5%) | 62 (89.9%) | 86 (52.8%) | 24 (33.3%) | 62 (68.1%) | 86 (52.8%) | |
Total | 73(100.0%) | 90(100.0%) | 163(100.0%) | 94(100.0%) | 69(100.0%) | 163(100.0%) | 72(100.0%) | 91(100.0%) | 163(100.0%) | |
p-value | Â Â Â Â Â Â Â Â Â Â Â Â Â < 0.001 | Â Â Â Â Â Â Â Â Â Â Â Â Â < 0.001 | Â Â Â Â Â Â Â Â Â Â Â Â < 0.001 |